Abstract
Identification of physiological and molecular markers is paramount in identifying patients at risk of faster progression of calcific aortic valve stenosis (pCAVS). A systematic review was conducted in accordance with the PRISMA guidelines. A search was performed using the PubMed, Cochrane library,
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
